Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results

被引：0
|
作者：
Izzo, F.
Catino, A. M.
Vogl, T. J.
Middleton, M.
Valle, J. W.
Fiore, F.
Gadaleta, C. D.
Pirotta, R. M.
Martignoni, M.
Laffranchi, B.
机构：
[1] NCI, Fdn G Pascale, Naples, Italy
[2] IRCCS Osped Oncol, Bari, Italy
[3] Hosp Johann Wolfgang Goethe Univ, Frankfurt, Germany
[4] Univ Oxford, Churchill Hosp, Oxford, England
[5] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[6] Nerviano Med Sci, Nerviano, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4593
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II trial of combination docetaxel and cisplatin in patients with locally advanced nasopharyngeal carcinoma
    Yamouni, M.
    Benhadji, K. A.
    Beldjilali, Y.
    Lahfa, I.
    Khellafi, H.
    Abdelaoui, A.
    Djellali, L.
    Bouzid, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Combination gemcitabine and cisplatin are highly active in endometrial carcinoma: Results of a prospective phase II trial
    Brown, J.
    Sood, A.
    Ramirez, P.
    Ramondetta, L.
    Coleman, R.
    Levenback, C.
    Jung, M.
    Wolf, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S21 - S21
  • [33] PHASE II STUDY OF EVEROLIMUS AND CAPECITABINE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC). RESULTS OF THE FIRST 10 PATIENTS INCLUDED
    Luelmo, S.
    Osanto, S.
    Weijl, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 256 - 257
  • [34] Phase II trial investigating the efficacy and safety of sunitinib in patients with unresectable hepatocellular carcinoma (HCC)
    Faivre, S. J.
    Raymond, E.
    Douillard, J.
    Boucher, E.
    Lim, H. Y.
    Kim, J. S.
    Lanzalone, S.
    Lechuga, M. J.
    Sherman, L.
    Cheng, A. L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 270 - 270
  • [35] Tivantinib (ARQ 197) versus placebo in patients (Pts) with hepatocellular carcinoma (HCC) who failed one systemic therapy: Results of a randomized controlled phase II trial (RCT)
    Rimassa, Lorenza
    Porta, Camillo
    Borbath, Ivan
    Daniele, Bruno
    Salvagni, Stefania
    Van Laethem, Jean Luc
    Van Vlieberghe, Hans
    Trojan, Jorg
    Kolligs, Frank T.
    Weiss, Alan
    Barahona, Nancy
    Gasbarrini, Antonio
    Lencioni, Monica
    Pande, Amitkumar U.
    Lamar, Maria
    Chen, Yinpu
    Schwartz, Brian E.
    Abbadessa, Giovanni
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Phase II trial of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma (HCC)
    He, Aiwu Ruth
    Tesfaye, Anteneh
    Smith, Daniel
    Marshall, John
    Pishvaian, Michael J.
    Smaglo, Brandon George
    Weiner, Louis M.
    Dorsch-Vogel, Karen
    Wang, Hongkun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [37] Phase I/II trial of continuous hepatic arterial infusion (HAI) of irinotecan in patients with hepatocellular carcinoma (HCC). Preliminary results
    Brandi, G.
    Derenzini, E.
    Pantaleo, M. A.
    Piscaglia, F.
    Golfieri, R.
    Bolondi, L.
    Mirarchi, M. G.
    Danesi, R.
    Biasco, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI50 - XI50
  • [38] A phase II study of bevacizumab (B) and erlotinib (E) in combination for Asian patients (pts) with advanced/metastatic hepatocellular carcinoma (HCC): An interim safety report
    Hsu, C.
    Kang, Y.
    Yang, T.
    Su, W.
    Sandoval-Tan, J.
    Chiou, T.
    Jin, K.
    Button, P.
    Hsu, C.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] A phase I/II study of the CXCR2 inhibitor, AZD5069, in combination with durvalumab, in patients (pts) with advanced hepatocellular carcinoma (HCC).
    Evans, T. R. Jeffry
    Basu, Bristi
    Hubner, Richard
    Ma, Yuk Ting
    Meyer, Tim
    Palmer, Daniel H.
    Pinato, David J. James
    Plummer, Elizabeth Ruth
    Ross, Paul J.
    Samson, Adel
    Sarker, Debashis
    Kendall, Timothy
    Bellamy, Christopher
    Reeves, Helen L.
    Thomson, Fiona
    Lawless, Claire A.
    Stobo, Jamie
    Sansom, Owen J.
    Mann, Derek A.
    Bird, Thomas G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS631 - TPS631
  • [40] A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of the nasopharynx:: updated results.
    Yamouni, M
    Benhadji, KA
    Beldjilali, Y
    Lahfa, I
    Yekrou, D
    Djellali, L
    Brahimi, M
    Aït-Said, M
    Bouzid, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 512S - 512S
12345